SGD Pharma

Activities: Packaging

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

SGD Pharma successfully trials hydrogen burners at its Saint-Quentin-Lamotte

SGD Pharma’s decarbonisation roadmap aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040
Packaging

SGD Pharma awarded 2024 gold EcoVadis rating

SGD Pharma’s sustainability rating of 77 puts the business in the 98th percentile for manufacturers of glass and glass products
Drug Delivery

SGD Pharma introduces its new range of Type I tubular vials

SGD partner with Corning to announce its new range of type I injectable vials in tubular glass with an added external low-friction coating
Packaging

SGD Pharma expands capacity for siliconised glass vials with new production lines

SGD Pharma announces the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant
Media

SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit

The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe
Packaging

SGD Pharma defines 2024 growth strategy as it strives for market leadership

SGD Pharma announces its goal to become the global market leader in primary pharmaceutical glass packaging
Sustainability

SGD Pharma commits to near-term science-based targets initiative as part of sustainability drive

SGD Pharma announces its commitment to company wide emissions reductions as part of its decarbonisation strategy by joining the Science Based Targets initiative (SBTi)
Subscribe now